Determination of flurbiprofen enantiomers in plasma using a single-isomer amino cyclodextrin derivative in nonaqueous capillary electrophoresis

Electrophoresis

Volumn 29, Issue 17, 2008, Pages 3641-3648

  Rousseau, Anne ^a   Pedrini, Matteo ^a   Chiap, Patrice ^b   Ivanyi, Robert ^c   Crommen, Jacques ^a   Fillet, Marianne ^a   Servais, Anne Catherine ^a  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

^c CycloLab Cyclodextrin Research & Development Laboratory Ltd   (Hungary)

Author keywords

Cationic cyclodextrin; Flurbiprofen; Nonaqueous capillary electrophoresis; Plasma samples; Quantitative determination

Indexed keywords

CAPILLARY ELECTROPHORESIS; CYCLODEXTRINS; ELECTROLYTES; EXTRACTION; HYDROPHOBICITY; PHASE SEPARATION;

CATIONIC CYCLODEXTRIN; CHIRAL SELECTOR; CYCLODEXTRIN DERIVATIVES; FLURBIPROFEN; NON-AQUEOUS; NON-AQUEOUS CAPILLARY ELECTROPHORESIS; PLASMA SAMPLES; QUANTITATIVE DETERMINATIONS; SINGLE-ISOMER; SOLID-PHASE EXTRACTION;

ENANTIOMERS;

6 MONODEOXY 6 MONO(3 HYDROXY)PROPYLAMINO BETA CYCLODEXTRIN; AMMONIUM ACETATE; BETA CYCLODEXTRIN DERIVATIVE; FLUFENAMIC ACID; FLURBIPROFEN; METHANOL; NONSTEROID ANTIINFLAMMATORY AGENT; TRIFLUOROACETIC ACID; UNCLASSIFIED DRUG;

ACCURACY; ANION EXCHANGE; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; ENANTIOMER; HUMAN; HYDROPHOBICITY; MOLECULAR INTERACTION; NONAQUEOUS CAPILLARY ELECTROPHORESIS; PROCESS OPTIMIZATION; PROTEIN DENATURATION; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; VALIDATION PROCESS;

EID: 53149096571     PISSN: 01730835     EISSN: 15222683     Source Type: Journal    
DOI: 10.1002/elps.200700919     Document Type: Article

References (26)

1. Ward, T., Anal. Chem. 2002, 74, 2863-2872.
2. Chankvetadze, B., Blaschke, G., Electrophoresis 2000, 21, 4159-4178.
3. Wang, F., Khaledi, M. G., J. Chromatogr. A 2000, 875, 277-293.
4. Steiner, F., Hassel, M., Electrophoresis 2000, 21, 3994-4016.
5. Fillet, M., Servais, A.-C., Crommen, J., Electrophoresis 2003, 24, 1499-1507.
6. Amini, A., Electrophoresis 2001, 22, 3107-3130.
7. Gilbitz, G., Schmid, M. G., Electrophoresis 2000, 21, 4112-4135.
8. Lelièvre, F., Gareil, P., Anal. Chem. 1997, 69, 385-392.
9. Fanali, S., Desiderio, C., Aturki, Z., J. Chromatogr. A 1997, 772, 185-194.
10. Galaverna, G., Paganuzzi, M. C., Corradini, R., Dossona, A., Marchelli, R., Electrophoresis 2001, 22, 3171-3177.
11. Budanova, N., Shapovalova, E., Lopatin, S., Varlamov, V., Shpigun, O., Electrophoresis 2004, 25, 2795-2800.
12. Bunke, A., Jira, T., J. Chromatogr. A 1998, 798, 275-280.
13. Fradi, I., Servais, A.-C., Pedrini, M., Chiap, P. et al., Electrophoresis 2006, 27, 3434-3442.
14. Panico, A. M., Cardile, V., Vittorio, F., Ronsisvalle, G. at al., II Farmaco 2003, 58, 1339-1344.
15. Brune, K., Beck, W. S., Geisslinger, G., Menzel-Soglowek, S. et al., Experientia 1991, 47, 257-261.
16. Eriksen, J. L., Sagi, S. A., Smith, T. E., Weggen, S. et al., J. Clin. Invest. 2003, 112, 440-449.
17. Geerts, H., IDrugs 2007, 10, 121-133.
18. Knadler, M. P., Hall, S. D., J. Chromatogr. B 1989, 494, 173-182.
19. Geisslinger, G., Menzel-Soglowek, S., Schuster, O., Brune, K., J. Chromatogr. B 1992, 573, 163-167.
20. Teng, X. W., Wang, S. W. J., Davies, N. M., J. Pharm. Biomed. Anal. 2003, 33, 95-100.
21. Gówka, F. K., Karaźniewicz, M., J. Pharm. Biomed. Anal. 2004, 35, 807-816.
22. Hubert, P., Nguyen-huu, J.-J., Boulanger, B., Chapuzet, E. et al., STP Pharma Pratiques 2003, 13, 101-138.
23. The European Pharmacopoeia, 5th Edn, part 2.2.47, Council of Europe, Strasbourg, France, 2005.
24. Blanchard, J., J. Chromatogr. 1981, 226, 455-460.
25. Marini, R. D., Chiap, P., Boulanger, B., Rudaz, S. et al., Talanta 2006, 68, 1166-1175.
26. Suri, A., Grundy, B. L., Derendorf, H., Int. J. Clin. Pharmacol. Ther. 1997, 35, 1-8.